Interstitial Lung Disease (ILD) / Diffuse Parenchymal Lung Diseases (DPLD)
It covers a huge spectrum of disorders with complex interplay of clinical symptoms and diagnostic challenges. It is a group of disorders which makes the lungs shrink progressively with passage of time. Effective and early diagnosis can slow down the progression in most cases of these complex spectrum of disorders and reverse the damage in a selected few. The usual treatments involve patient centric rehabilitation, immunosuppressive agents, antifibrotics and vaccinations. These are decided after careful evaluation and detailed discussion among the experienced consultants of our department and other concerned departments
The common conditions referred or treated:
- IPF – Idiopathic Pulmonary Fibrosis – IPF
- HP- Hypersensitivity Pneumonitis – CHP
- NSIP – Non-specific Interstitial Pneumonia
- Sarcoidosis
- Vasculitis affecting lungs
- Interstitial Lung Diseases related to connective tissue diseases
- Drug induced lung diseases
- Occupational lung diseases
- OP – Organizing Pneumonia
- RBILD – Respiratory Bronchiolitis Interstitial Lung Disease
- DIP – Desquamative Interstitial Pneumonia
- AIP – Acute Interstitial Pneumonia
- LIP – Lymphocytic Interstitial Pneumonia
- PPFE – Pleuro-parenchymal fibroelastosis
- CPFE – Combined pulmonary fibrosis and emphysema
- LAM – Lymphangioleiomyomatosis
- LCH – Langerhans Cell Histiocytosis
